ATE348809T1
Imides as inhibitors of TNF alpha
Abstract
A process of preparing thalidomide in which N-phthaloylglutamine or N-phthaloylisoglutamine is cyclized with N,N'-carbonyldiimidazole, characterised in that the process comprises heating said N-phthaloylglutamine or N-phthaloylisoglutamine and N,N'-carbonyldiimidazole in refluxing anhydrous tetrahydrofuran.
Term
Term ended
Projected expiry passed 1 July 2014, 12.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
84 members in 20 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 8751093 | United States of America | A |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| CA2166315A1 | Canada | A1 | |
| CA2531868A1 | Canada | A1 | |
| CA2626178A1 | Canada | A1 | |
| WO9501348A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7216794A | Australia | A | |
| WO9501348A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5463063A | United States of America | A | |
| FI956362A | Finland | A | |
| FI956362L | Finland | L | |
| HU9600003D0 | Hungary | D0 | |
| PL312386A1 | Poland | A1 | |
| EP0706521A1 | European Patent Office (EPO) | A1 | |
| KR960703891A | Republic of Korea | A | |
| CZ1096A3 | Czechia | A3 | |
| SK166595A3 | Slovakia | A3 | |
| JPH09500872A | Japan | A | |
| US5605914A | United States of America | A | |
| HUT75312A | Hungary | A | |
| US5698579A | United States of America | A | |
| AU687843B2 | Australia | B2 | |
| NZ268812A | New Zealand | A | |
| NZ329259A | New Zealand | A | |
| US5877200A | United States of America | A | |
| NZ329258A | New Zealand | A | |
| EP1004572A2 | European Patent Office (EPO) | A2 | |
| EP1004580A2 | European Patent Office (EPO) | A2 | |
| EP1004581A2 | European Patent Office (EPO) | A2 | |
| US6075041A | United States of America | A | |
| HK1025765A1 | Hong Kong, China | A1 | |
| HK1025769A1 | Hong Kong, China | A1 | |
| PL180377B1 | Poland | B1 | |
| US6200987B1 | United States of America | B1 | |
| RU2174516C2 | Russian Federation | C2 | |
| EP1004581A3 | European Patent Office (EPO) | A3 | |
| EP0706521B1 | European Patent Office (EPO) | B1 | |
| EP1004572A3 | European Patent Office (EPO) | A3 | |
| EP1004580A3 | European Patent Office (EPO) | A3 | |
| AT225344T | Austria | T | |
| ATE225344T1 | Austria | T1 | |
| DE69431480D1 | Germany | D1 | |
| DK0706521T3 | Denmark | T3 | |
| PT706521E | Portugal | E | |
| ES2184765T3 | Spain | T3 | |
| HK1025770A1 | Hong Kong, China | A1 | |
| DE69431480T2 | Germany | T2 | |
| FI20040593A | Finland | A | |
| FI20040593A7 | Finland | A7 | |
| EP1004581B1 | European Patent Office (EPO) | B1 | |
| AT277036T | Austria | T | |
| ATE277036T1 | Austria | T1 | |
| DE69434029D1 | Germany | D1 | |
| EP1477486A2 | European Patent Office (EPO) | A2 | |
| EP1477486A3 | European Patent Office (EPO) | A3 | |
| CZ294444B6 | Czechia | B6 | |
| DK1004581T3 | Denmark | T3 | |
| PT1004581E | Portugal | E | |
| FI114984B | Finland | B | |
| ES2226696T3 | Spain | T3 | |
| DE69434029T2 | Germany | T2 | |
| KR100401290B1 | Republic of Korea | B1 | |
| EP1004572B1 | European Patent Office (EPO) | B1 | |
| AT319678T | Austria | T | |
| ATE319678T1 | Austria | T1 | |
| CA2166315C | Canada | C | |
| DE69434645D1 | Germany | D1 | |
| JP2006131647A | Japan | A | |
| JP2006169261A | Japan | A | |
| PT1004572E | Portugal | E | |
| DK1004572T3 | Denmark | T3 | |
| JP2006188529A | Japan | A | |
| JP2006188530A | Japan | A | |
| ES2258956T3 | Spain | T3 | |
| DE69434645T2 | Germany | T2 | |
| EP1004580B1 | European Patent Office (EPO) | B1 | |
| AT348809T | Austria | T | |
| ATE348809T1This record | Austria | T1 | |
| DE69434895D1 | Germany | D1 | |
| PT1004580E | Portugal | E | |
| DK1004580T3 | Denmark | T3 | |
| DE69434895T2 | Germany | T2 | |
| ES2278574T3 | Spain | T3 | |
| JP3971794B2 | Japan | B2 | |
| JP4461107B2 | Japan | B2 | |
| CA2531868C | Canada | C |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 200491
Titles2
- English
- IMIDES AS INHIBITORS OF TNF ALPHA
- German
- IMIDE ALS INHIBITOREN VON TNF ALPHA
Classification
- CPC, 38
- C07D209/48
- C07D401/04
- C07C229/34
- C07D209/46
- C07D211/88
- C07D213/55
- C07D401/06
- C07D401/12
- C07D403/06
- C07D405/12
- A61P1/04
- A61P11/00
- A61P17/00
- A61P17/02
- A61P17/06
- A61P19/02
- A61P21/00
- A61P25/00
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/12
- A61P31/14
- A61P31/16
- A61P31/18
- A61P31/20
- A61P31/22
- A61P33/06
- A61P35/00
- A61P37/00
- A61P37/04
- A61P37/06
- A61P43/00
- A61P7/08
- A61P9/00
- A61P9/02
- A61P9/04
- A61P9/10
- IPC, 45
- C07D307 66
- A61K31 16
- A61K31 165
- A61K31 215
- A61K31 275
- A61K31 33
- A61K31 34
- A61K31 341
- A61K31 40
- A61K31 403
- A61K31 404
- A61K31 405
- A61K31 415
- A61K31 435
- A61K31 44
- A61K31 4427
- A61K31 443
- A61K31 4465
- A61K31 45
- A61K31 454
- A61P31 12
- A61P35 00
- A61P37 04
- A61P43 00
- C07C229 08
- C07C229 20
- C07C229 22
- C07C229 34
- C07C237 04
- C07C255 50
- C07D209 08
- C07D209 18
- C07D209 46
- C07D209 48
- C07D209 76
- C07D211 88
- C07D213 55
- C07D401 04
- C07D401 06
- C07D401 12
- C07D403 06
- C07D405 12
- C07D471 04
- C07D487 04
- C07D495 04